Logo Perrigo

Perrigo (PRGO) stock: analyst price target and their real reliability

Live quote · data updated Aug 28, 2026
Perrigo · Health Care · ref. ETF XLV · 68 calls · price $14.37
💬JPI AI AssistantTry it →
What the company does: Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

📈 Perrigo (PRGO) stock price

$14.37-39.5% over range
Aug 28, 25low $9.25 · high $23.76Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
No recent rating
📊 JPI status : Perrigo has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →

🎯 PRGO price target & analyst consensusprice $14.37

The price target
Highest target
Median target
Lowest target
Current price$14.37
⭐ What the most reliable analysts say

No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.

The consensus · 0 ratings (last 6 months)
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about Perrigo? The JPI assistant answers using our backtest data.

🔎 Detailed analyses

✅ Historical analyst reliability on PRGO

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm % right i Gain vs sector i Calls i
Morgan Stanley  100% +30.0% 5
RBC Capital  67% +18.2% 3
B of A Securities  67% +6.5% 3
Stifel  60% +17.4% 5
UBS  60% +8.1% 5
Cantor Fitzgerald  50% -12.9% 2
Jefferies  40% -7.3% 5
Goldman Sachs  40% -15.2% 5
Canaccord Genuity  38% -6.9% 8
CRT Capital 33% +2.8% 3
See the other 9 firms
B. Riley Securities  0% -43.3% 3
Barclays  0% -29.2% 3
Wells Fargo  0% -22.0% 2
Piper Sandler  0% -9.3% 4
Argus Research  17% -23.1% 6
Deutsche Bank  20% -21.7% 10
Raymond James  20% -13.1% 5
JP Morgan  33% -8.6% 6
SVB Leerink 33% -8.5% 3

📊 What $1,000 invested in Perrigo would be worth › open the full page

In short — $1,000 invested in Perrigo 10 years ago would be worth $68.42 today, i.e. -24%/yr on average. Best year: 2019 (+33%), worst: 2018 (-56%). Price performance, excluding dividends.

If I'd invested $1,000 in Perrigo

InvestmentWorth todayGain
1 years ago$385-61%
3 years ago$290-71%
5 years ago$221-78%
→ See Perrigo's full return history + gain calculator

Return by year (Perrigo)

YearReturn$1,000 invested at year start
2026 (YTD)-29%$711 (-29%)
2025-46%$385 (-61%)
2024-20%$308 (-69%)
→ See Perrigo's full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on Perrigo

Loading news…

📋 All analyst calls on PRGO

▲ Buy · 🎯$17
Price at call : $12.34 — upside +38%
Today : $14.37 — upside +18%
🎯 on PRGO : 38% (8 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Feb 27, 27
JP Morgan 
Dec 15, 25
■ Neutral neutral · not a buy · 🎯$18
Price at call : $13.02 — gap to target +38%
Today : $14.37 — gap to target +25%
🎯 on PRGO : 25% (4 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : Dec 15, 26
▲ Buy · 🎯$20
Price at call : $14.44 — upside +39%
Today : $14.37 — upside +39%
🎯 on PRGO : 38% (8 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Nov 6, 26
JP Morgan 
Nov 6, 25
■ Neutral neutral · not a buy · 🎯$20
Price at call : $14.93 — gap to target +34%
Today : $14.37 — gap to target +39%
🎯 on PRGO : 25% (4 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : Nov 6, 26
Jefferies 
Oct 27, 25
■ Hold neutral · not a buy · 🎯$23
Price at call : $21.94 — gap to target +5%
Today : $14.37 — gap to target +60%
🎯 on PRGO : 0% (1 call matured) · 📊 on Health : 50% · +9.9% (136 calls)
in progress (365j)
matures : Oct 27, 26
▲ Buy · 🎯$40
Price at call : $22.55 — upside +77%
Today : $14.37 — upside +178%
Expected +77% · Actual -44% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 38% (8 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
-44.0%
stock -44% · XLV +29%
matured Aug 8, 26
JP Morgan 
Aug 7, 25
▲ Overweight · 🎯$35
Price at call : $22.55 — upside +55%
Today : $14.37 — upside +144%
Expected +55% · Actual -44% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 25% (4 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
-44.0%
stock -44% · XLV +29%
matured Aug 7, 26
Piper Sandler 
Jan 6, 25
■ Neutral neutral · not a buy · 🎯$27
Price at call : $24.95 — gap to target +8%
Today : $14.37 — gap to target +88%
🎯 on PRGO : 0% (4 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
in progress (365j)
matures : Jan 6, 26
See the other 60 calls, newest to oldest
▲ Buy · 🎯$42
Price at call : $25.46 — upside +65%
Today : $14.37 — upside +192%
Expected +65% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 38% (8 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
-11.6%
stock -12% · XLV -6%
matured Sep 30, 25
Jefferies 
Sep 23, 24
■ Hold neutral · not a buy · 🎯$30
Price at call : $26.54 — gap to target +13%
Today : $14.37 — gap to target +109%
🎯 on PRGO : 0% (1 call matured) · 📊 on Health : 50% · +9.9% (136 calls)
in progress (365j)
matures : Sep 23, 25
Piper Sandler 
Jul 11, 24
▲ Overweight · 🎯$35
Price at call : $27.84 — upside +26%
Today : $14.37 — upside +144%
Expected +26% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 0% (4 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-1.1%
stock -1% · XLV -8%
matured Jul 11, 25
Piper Sandler 
Jun 13, 24
▲ Overweight · 🎯$36
Price at call : $27.39 — upside +31%
Today : $14.37 — upside +151%
Expected +31% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 0% (4 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-2.7%
stock -3% · XLV -7%
matured Jun 13, 25
▲ Buy · 🎯$42
Price at call : $30.13 — upside +39%
Today : $14.37 — upside +192%
Expected +39% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 38% (8 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
-17.0%
stock -17% · XLV -0%
matured Apr 12, 25
Piper Sandler 
Apr 8, 24
▲ Overweight · 🎯$39
Price at call : $31.75 — upside +23%
Today : $14.37 — upside +171%
Expected +23% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 0% (4 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-22.7%
stock -23% · XLV -7%
matured Apr 8, 25
JP Morgan 
Feb 28, 24
▲ Overweight · 🎯$41
Price at call : $26.26 — upside +56%
Today : $14.37 — upside +185%
Expected +56% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 25% (4 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
+10.4%
stock +10% · XLV +3%
matured Feb 27, 25
Piper Sandler 
Nov 17, 23
▲ Overweight · 🎯$37
Price at call : $30.11 — upside +23%
Today : $14.37 — upside +157%
Expected +23% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 0% (4 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-10.7%
stock -11% · XLV +11%
matured Nov 16, 24
JP Morgan 
Aug 9, 23
▲ Overweight · 🎯$48
Price at call : $38.5 — upside +25%
Today : $14.37 — upside +234%
Expected +25% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 25% (4 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
-30.1%
stock -30% · XLV +11%
matured Aug 8, 24
▲ Buy · 🎯$49
Price at call : $37.71 — upside +30%
Today : $14.37 — upside +241%
Expected +30% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 38% (8 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
-25.5%
stock -26% · XLV +15%
matured Mar 6, 24
Raymond James 
Mar 6, 23
▲ Outperform · 🎯$43
Price at call : $36.96 — upside +16%
Today : $14.37 — upside +199%
Expected +16% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 20% (5 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
-26.2%
stock -26% · XLV +12%
matured Mar 5, 24
Raymond James 
Nov 9, 22
▲ Outperform · 🎯$42
Price at call : $32.08 — upside +31%
Today : $14.37 — upside +192%
Expected +31% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 20% (5 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
-12.4%
stock -12% · XLV -5%
matured Nov 9, 23
Argus Research 
Sep 14, 22
▲ Buy · 🎯$46
Price at call : $40.05 — upside +15%
Today : $14.37 — upside +220%
Expected +15% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 17% (6 calls matureds) · 📊 on Health : 18.2% · -27.9% (11 calls)
-16.0%
stock -16% · XLV +5%
matured Sep 14, 23
Wells Fargo 
Sep 6, 22
▲ Overweight · 🎯$54
Price at call : $37.95 — upside +42%
Today : $14.37 — upside +276%
Expected +42% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 0% (1 call matured) · 📊 on Health : 37.5% · +1.0% (104 calls)
-9.4%
stock -9% · XLV +5%
matured Sep 6, 23
Raymond James 
May 4, 22
▲ Outperform · 🎯$48
Price at call : $33.25 — upside +44%
Today : $14.37 — upside +234%
Expected +44% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 20% (5 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
+11.1%
stock +11% · XLV -0%
matured May 4, 23
Raymond James 
Nov 11, 21
▲ Outperform · 🎯$55
Price at call : $43.3 — upside +27%
Today : $14.37 — upside +283%
Expected +27% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 20% (5 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
-22.8%
stock -23% · XLV -0%
matured Nov 11, 22
Raymond James 
Oct 14, 21
▲ Outperform · 🎯$59
Price at call : $45.47 — upside +30%
Today : $14.37 — upside +311%
Expected +30% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 20% (5 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
-14.9%
stock -15% · XLV -3%
matured Oct 14, 22
Jefferies 
Sep 30, 21
▲ Buy · 🎯$63
Price at call : $47.33 — upside +33%
Today : $14.37 — upside +338%
Expected +33% · Actual -25% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 0% (1 call matured) · 📊 on Health : 50% · +9.9% (136 calls)
-24.7%
stock -25% · XLV -5%
matured Sep 30, 22
■ Equal-Weight neutral · not a buy · 🎯$45
Price at call : $41.04 — gap to target +10%
Today : $14.37 — gap to target +213%
🎯 on PRGO : no call matured yet · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Mar 5, 22
RBC Capital 
Jan 6, 21
■ Sector Perform neutral · not a buy · 🎯$49
Price at call : $44.83 — gap to target +9%
Today : $14.37 — gap to target +241%
🎯 on PRGO : no call matured yet · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Jan 6, 22
Wells Fargo 
Oct 28, 20
■ Equal-Weight neutral · not a buy · 🎯$49
Price at call : $42.53 — gap to target +15%
Today : $14.37 — gap to target +241%
🎯 on PRGO : 0% (1 call matured) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Oct 28, 21
SVB Leerink
Sep 17, 20
▲ Outperform · 🎯$63
Price at call : $47.07 — upside +34%
Today : $14.37 — upside +338%
Expected +34% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 33% (3 calls matureds) · 📊 unranked overall
-7.9%
stock -8% · XLV +24%
matured Sep 17, 21
SVB Leerink
Jun 8, 20
▲ Outperform · 🎯$63
Price at call : $57.73 — upside +9%
Today : $14.37 — upside +338%
Expected +9% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 33% (3 calls matureds) · 📊 unranked overall
-18.5%
stock -19% · XLV +18%
matured Jun 8, 21
Argus Research 
Apr 17, 20
■ Hold neutral · not a buy
🎯 on PRGO : 17% (6 calls matureds) · 📊 on Health : 18.2% · -27.9% (11 calls)
in progress (365j)
matures : Apr 17, 21
■ Equal-Weight neutral · not a buy · 🎯$53
Price at call : $42.8 — gap to target +24%
Today : $14.37 — gap to target +269%
🎯 on PRGO : no call matured yet · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Apr 2, 21
JP Morgan 
Mar 24, 20
▲ Overweight · 🎯$57
Price at call : $45.21 — upside +26%
Today : $14.37 — upside +297%
Expected +26% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 25% (4 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
-6.2%
stock -6% · XLV +42%
matured Mar 24, 21
SVB Leerink
Mar 20, 20
▲ Outperform · 🎯$52
Price at call : $42.13 — upside +23%
Today : $14.37 — upside +262%
Expected +23% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 33% (3 calls matureds) · 📊 unranked overall
+1.0%
stock +1% · XLV +46%
matured Mar 20, 21
Wells Fargo 
Mar 11, 20
■ Equal-Weight neutral · not a buy · 🎯$53
Price at call : $46.04 — gap to target +15%
Today : $14.37 — gap to target +269%
🎯 on PRGO : 0% (1 call matured) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Mar 11, 21
▲ Overweight · 🎯$70
Price at call : $59.83 — upside +17%
Today : $14.37 — upside +387%
Expected +17% · Actual -28% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 0% (1 call matured) · 📊 on Health : 50.6% · +13.8% (166 calls)
-27.7%
stock -28% · XLV +13%
matured Jan 20, 21
Argus Research 
Oct 11, 19
▲ Buy
Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 17% (6 calls matureds) · 📊 on Health : 18.2% · -27.9% (11 calls)
-13.2%
stock -13% · XLV +21%
matured Oct 10, 20
Wells Fargo 
Sep 30, 19
■ Market Perform neutral · not a buy · 🎯$52
Price at call : $55.89 — gap to target -7%
Today : $14.37 — gap to target +262%
🎯 on PRGO : 0% (1 call matured) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Sep 29, 20
■ Hold neutral · not a buy · 🎯$55
Price at call : $55.22 — gap to target -0%
Today : $14.37 — gap to target +283%
🎯 on PRGO : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Sep 24, 20
Morgan Stanley 
Mar 26, 19
■ Equal-Weight neutral · not a buy · 🎯$54
Price at call : $47.44 — gap to target +14%
Today : $14.37 — gap to target +276%
🎯 on PRGO : no call matured yet · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Mar 25, 20
■ Hold neutral · not a buy · 🎯$51
Price at call : $48.35 — gap to target +5%
Today : $14.37 — gap to target +255%
🎯 on PRGO : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Mar 19, 20
Wells Fargo 
Dec 21, 18
■ Market Perform neutral · not a buy · 🎯$46
Price at call : $37.03 — gap to target +24%
Today : $14.37 — gap to target +220%
🎯 on PRGO : 0% (1 call matured) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Dec 21, 19
Morgan Stanley 
Nov 13, 18
■ Equal-Weight neutral · not a buy · 🎯$67
Price at call : $65.39 — gap to target +2%
Today : $14.37 — gap to target +366%
🎯 on PRGO : no call matured yet · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Nov 13, 19
Berenberg 
Nov 13, 18
■ Hold neutral · not a buy · 🎯$72
Price at call : $65.39 — gap to target +10%
Today : $14.37 — gap to target +401%
🎯 on PRGO : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Nov 13, 19
Wells Fargo 
Aug 21, 18
■ Market Perform neutral · not a buy · 🎯$77
Price at call : $74.07 — gap to target +4%
Today : $14.37 — gap to target +436%
🎯 on PRGO : 0% (1 call matured) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Aug 21, 19
RBC Capital 
Aug 10, 18
■ Sector Perform neutral · not a buy · 🎯$67
Price at call : $69.64 — gap to target -4%
Today : $14.37 — gap to target +366%
🎯 on PRGO : no call matured yet · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Aug 10, 19
JP Morgan 
Aug 10, 18
■ Neutral neutral · not a buy · 🎯$75
Price at call : $69.9 — gap to target +7%
Today : $14.37 — gap to target +422%
🎯 on PRGO : 25% (4 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : Aug 10, 19
Deutsche Bank 
Aug 10, 18
■ Hold neutral · not a buy · 🎯$78
Price at call : $69.9 — gap to target +12%
Today : $14.37 — gap to target +443%
🎯 on PRGO : 20% (10 calls matureds) · 📊 on Health : 32.7% · -7.6% (55 calls)
in progress (365j)
matures : Aug 10, 19
Argus Research 
Jul 30, 18
■ Hold neutral · not a buy
🎯 on PRGO : 17% (6 calls matureds) · 📊 on Health : 18.2% · -27.9% (11 calls)
in progress (365j)
matures : Jul 30, 19
▲ Buy
Actual -31% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 17% (6 calls matureds) · 📊 on Health : 18.2% · -27.9% (11 calls)
-31.3%
stock -31% · XLV +10%
matured Dec 8, 18
▲ Buy · 🎯$100
Price at call : $88.87 — upside +13%
Today : $14.37 — upside +596%
Expected +13% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 38% (8 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
-17.1%
stock -17% · XLV +12%
matured Sep 13, 18
Deutsche Bank 
Jul 17, 17
▲ Buy · 🎯$88
Price at call : $72.9 — upside +21%
Today : $14.37 — upside +512%
Expected +21% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 20% (10 calls matureds) · 📊 on Health : 32.7% · -7.6% (55 calls)
+4.8%
stock +5% · XLV +9%
matured Jul 17, 18
▲ Buy
Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 38% (8 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
+3.5%
stock +4% · XLV +14%
matured Feb 22, 18
Deutsche Bank 
Aug 11, 16
▲ Buy · 🎯$105
Price at call : $87.96 — upside +19%
Today : $14.37 — upside +631%
Expected +19% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 20% (10 calls matureds) · 📊 on Health : 32.7% · -7.6% (55 calls)
-12.1%
stock -12% · XLV +6%
matured Aug 11, 17
Deutsche Bank 
Jul 22, 16
▲ Buy
Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 20% (10 calls matureds) · 📊 on Health : 32.7% · -7.6% (55 calls)
-17.4%
stock -17% · XLV +8%
matured Jul 22, 17
▲ Buy
Actual -48% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 17% (6 calls matureds) · 📊 on Health : 18.2% · -27.9% (11 calls)
-48.3%
stock -48% · XLV +6%
matured Apr 6, 17
Deutsche Bank 
Feb 19, 16
▲ Buy · 🎯$172
Price at call : $124.08 — upside +39%
Today : $14.37 — upside +1097%
Expected +39% · Actual -32% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 20% (10 calls matureds) · 📊 on Health : 32.7% · -7.6% (55 calls)
-31.8%
stock -32% · XLV +11%
matured Feb 18, 17
Deutsche Bank 
Feb 18, 16
▲ Buy · 🎯$172
Price at call : $129.34 — upside +33%
Today : $14.37 — upside +1097%
Expected +33% · Actual -35% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 20% (10 calls matureds) · 📊 on Health : 32.7% · -7.6% (55 calls)
-34.5%
stock -35% · XLV +12%
matured Feb 17, 17
Argus Research 
Dec 10, 15
▲ Buy
Actual -45% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 17% (6 calls matureds) · 📊 on Health : 18.2% · -27.9% (11 calls)
-44.6%
stock -45% · XLV -4%
matured Dec 9, 16
Deutsche Bank 
Oct 23, 15
▲ Buy · 🎯$187
Price at call : $154.27 — upside +21%
Today : $14.37 — upside +1201%
Expected +21% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 20% (10 calls matureds) · 📊 on Health : 32.7% · -7.6% (55 calls)
-41.3%
stock -41% · XLV -0%
matured Oct 22, 16
Deutsche Bank 
Apr 23, 15
▲ Buy · 🎯$208
Price at call : $192.89 — upside +8%
Today : $14.37 — upside +1347%
Expected +8% · Actual -48% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 20% (10 calls matureds) · 📊 on Health : 32.7% · -7.6% (55 calls)
-48.5%
stock -48% · XLV -4%
matured Apr 22, 16
Deutsche Bank 
Apr 13, 15
▲ Buy · 🎯$205
Price at call : $201.88 — upside +2%
Today : $14.37 — upside +1327%
Expected +2% · Actual -38% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 20% (10 calls matureds) · 📊 on Health : 32.7% · -7.6% (55 calls)
-37.7%
stock -38% · XLV -6%
matured Apr 12, 16
Deutsche Bank 
Mar 3, 15
▲ Buy · 🎯$200
Price at call : $156.22 — upside +28%
Today : $14.37 — upside +1292%
Expected +28% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 20% (10 calls matureds) · 📊 on Health : 32.7% · -7.6% (55 calls)
-19.5%
stock -19% · XLV -6%
matured Mar 2, 16
Argus Research 
Oct 21, 13
▲ Buy
Actual +15% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 17% (6 calls matureds) · 📊 on Health : 18.2% · -27.9% (11 calls)
+14.7%
stock +15% · XLV +20%
matured Oct 21, 14
Deutsche Bank 
Jul 30, 13
▲ Buy · 🎯$150
Price at call : $124.39 — upside +21%
Today : $14.37 — upside +944%
Expected +21% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on PRGO : 20% (10 calls matureds) · 📊 on Health : 32.7% · -7.6% (55 calls)
+20.9%
stock +21% · XLV +19%
matured Jul 30, 14
▲ Buy · 🎯$128
Price at call : $105.75 — upside +21%
Today : $14.37 — upside +791%
Expected +21% · Actual +47% · Reason (≥ +15%) : ✓ Yes
🎯 on PRGO : 38% (8 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
+47.3%
stock +47% · XLV +30%
matured Feb 4, 14
▲ Buy · 🎯$125
Price at call : $105.5 — upside +18%
Today : $14.37 — upside +770%
Expected +18% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on PRGO : 38% (8 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
+9.0%
stock +9% · XLV +23%
matured Mar 5, 13

Frequently asked questions

Should I buy Perrigo stock?

This isn't buy advice. For Perrigo, the analyst consensus is "Hold". What matters is their past reliability on this stock: the most reliable one is right 100% of the time (5 calls tracked on Perrigo). We show the numbers — you decide.

Is Perrigo still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 19 analysts have a real record on Perrigo, the best hitting 100% over 5 calls. Current consensus: "Hold". Make your call on data, not noise.

Will Perrigo stock recover (go back up)?

It's down from its high. We answer with the numbers — the analysts' 12-month target and what happened after its past drops: will PRGO stock recover (go back up)?

What has Perrigo's past performance been?

Historical returns and a "how much if I had invested" calculator: PRGO performance & returns.

What is the best month to buy PRGO?

The 12 months ranked by the stock's past returns: best & worst month to buy PRGO.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)